328:
160:
140:
120:
563:
Suboxone. All other charges against
Indivior were dismissed. Together with a $ 1.4 billion resolution with Indivior's former parent, Reckitt Benckiser Group PLC (RB Group), announced in 2019, and a plea agreement with Indivior plc's former CEO, Shaun Thaxter, announced last month, the total resolution relating to the marketing of Suboxone is more than $ 2 billion.
26:
285:
In July 2023 Indivior paid $ 20.4 million to C4X Discovery for the full rights to the orexin-1 receptor antagonist being developed for substance use disorder. Indivior had already made an upfront payment of $ 10 million in 2018 and pledged milestone payments of up to $ 284 million. Under the new
562:
Indivior
Solutions today pleaded guilty to a one-count felony information and, together with its parent companies Indivior Inc. and Indivior PLC, agreed to pay a total of $ 600 million to resolve criminal and civil liability associated with the marketing of the opioid-addiction-treatment drug
225:
in 1994. In
December 2014, Reckitt Benckiser spun off its specialty pharmaceuticals business into a separate company named Indivior. By February 2015, the company was capitalised at £2.3 billion (US$ 3.1 billion) on the
549:
717:
384:
263:
In July 2020, Indivior
Solutions, Indivior Inc., and Indivior PLC agreed to pay $ 600 million to resolve liability related to false marketing of Suboxone to
602:
436:
541:
356:
490:
250:
193:
in 1994 and demerged from that company in
December 2014, the company has been fined for false marketing claims about the safety of its
722:
627:
267:
for use by patients with children under the age of six years old. Additionally, Indivior
Solutions Inc pleaded guilty to one-count of
132:
457:
652:
264:
576:
406:
678:
206:
515:
327:
275:
62:
233:
In 2019, Indivior was indicted over claims that it had made false marketing claims about the safety of its
238:
198:
227:
202:
48:
186:
314:
80:
289:
In May 2024, the company confirmed that it would transfer its primary share listing to the U.S.
253:
to pay $ 1.4 billion to resolve a U.S. Federal investigation into sales and marketing of opioid
542:"Indivior Solutions Pleads Guilty to Felony Charge as Part of DOJ's Largest Opioid Resolution"
465:
257:
222:
190:
603:"C4X sells full rights for substance use disorder drug to Indivior as part of refocus"
414:
711:
298:
218:
108:
42:
52:
317:: the company claims this to be the largest pipeline of addiction drugs in the
249:
who were likely to prescribe
Suboxone. Reckitt Benckiser has settled with the
152:
469:
437:"Is Indivior PLC The Perfect Partner For AstraZeneca plc in Your Portfolio?"
254:
246:
25:
653:"Drug firm Indivior plans to move primary listing to US in snub to London"
302:
93:
310:
242:
279:
268:
163:
143:
123:
516:"Reckitt to pay $ 1.4 billion to end long-running Indivior probes"
491:"Reckitt to pay $ 1.4 billion to end long-running Indivior probes"
458:"Reckitt to Pay $ 1.4 Billion to End Long-Running Indivior Probes"
318:
306:
234:
194:
305:-combined preparation Suboxone, both substitution products for
286:
agreement C4X Discovery waived any rights to further payment.
98:
274:
In
November 2022, it was announced Indivior had acquired the
702:
679:"RB spin-out Indivior says addiction pipeline will deliver"
628:"Indivior Shareholders Approve Main Listing Switch to U.S."
550:
United States Postal
Service Office of Inspector General
174:
170:
150:
130:
114:
104:
86:
76:
68:
58:
40:
32:
577:"Indivior to acquire US biopharmaceutical company"
313:and opioid analgesic overdose and treatment for
309:addiction. Other products include remedies for
8:
718:Pharmaceutical companies established in 1994
18:
379:
377:
297:The company's main products are Sublocade,
282:-listed biopharmaceutical company, Opiant.
24:
17:
351:
349:
347:
407:"RB complete demerger of Indivior - RB"
343:
323:
241:, and had concocted a scheme to direct
189:business. Established as a division of
387:. Investors Chronicle. 2 February 2015
7:
217:The company was established as the
413:. 23 December 2014. Archived from
385:"Indivior faces generic challenge"
14:
681:. Pharmaphorum. 21 November 2014
601:Waldron, James (1 August 2023).
326:
159:
158:
139:
138:
119:
118:
1:
207:NASDAQ Global Select Market
739:
109:Subutex/Subuxone/Sublocade
723:Companies based in Slough
126:1,093 million (2022)
23:
333:Suboxone sublingual film
146:(4) million (2022)
201:. It is listed on the
357:"Annual Results 2023"
228:London Stock Exchange
203:London Stock Exchange
166:2 million (2023)
92:Graham Hetherington,
20:
659:. 22 February 2024
495:Wall Street Report
462:The New York Times
315:alcohol dependence
251:Justice Department
81:Richmond, Virginia
581:Insider Media Ltd
223:Reckitt Benckiser
191:Reckitt Benckiser
180:
179:
175:www.indivior.com/
730:
691:
690:
688:
686:
675:
669:
668:
666:
664:
649:
643:
642:
640:
638:
624:
618:
617:
615:
613:
598:
592:
591:
589:
587:
575:Media, Insider.
572:
566:
565:
559:
557:
538:
532:
531:
529:
527:
512:
506:
505:
503:
501:
487:
481:
480:
478:
476:
464:. 11 July 2019.
454:
448:
447:
445:
443:
433:
427:
426:
424:
422:
417:on 29 March 2015
403:
397:
396:
394:
392:
381:
372:
371:
369:
367:
361:
353:
330:
278:-headquartered,
162:
161:
142:
141:
133:Operating income
122:
121:
28:
21:
738:
737:
733:
732:
731:
729:
728:
727:
708:
707:
699:
694:
684:
682:
677:
676:
672:
662:
660:
651:
650:
646:
636:
634:
626:
625:
621:
611:
609:
600:
599:
595:
585:
583:
574:
573:
569:
555:
553:
540:
539:
535:
525:
523:
514:
513:
509:
499:
497:
489:
488:
484:
474:
472:
456:
455:
451:
441:
439:
435:
434:
430:
420:
418:
405:
404:
400:
390:
388:
383:
382:
375:
365:
363:
359:
355:
354:
345:
341:
334:
331:
295:
215:
187:pharmaceuticals
185:is a specialty
155:
135:
97:Mark Crossley,
96:
89:
45:
12:
11:
5:
736:
734:
726:
725:
720:
710:
709:
706:
705:
698:
697:External links
695:
693:
692:
670:
644:
619:
607:Fierce Biotech
593:
567:
552:. 24 July 2020
533:
522:. 11 July 2019
507:
482:
449:
428:
398:
373:
342:
340:
337:
336:
335:
332:
325:
294:
291:
214:
211:
178:
177:
172:
168:
167:
156:
151:
148:
147:
136:
131:
128:
127:
116:
112:
111:
106:
102:
101:
90:
87:
84:
83:
78:
74:
73:
70:
66:
65:
60:
56:
55:
46:
41:
38:
37:
36:Public company
34:
30:
29:
13:
10:
9:
6:
4:
3:
2:
735:
724:
721:
719:
716:
715:
713:
704:
703:Official site
701:
700:
696:
680:
674:
671:
658:
654:
648:
645:
633:. 23 May 2024
632:
629:
623:
620:
608:
604:
597:
594:
582:
578:
571:
568:
564:
551:
547:
543:
537:
534:
521:
517:
511:
508:
496:
492:
486:
483:
471:
467:
463:
459:
453:
450:
438:
432:
429:
416:
412:
408:
402:
399:
386:
380:
378:
374:
358:
352:
350:
348:
344:
338:
329:
324:
322:
320:
316:
312:
308:
304:
300:
292:
290:
287:
283:
281:
277:
272:
271:information.
270:
266:
261:
259:
256:
252:
248:
244:
240:
236:
231:
229:
224:
220:
219:Buprenorphine
212:
210:
208:
204:
200:
196:
192:
188:
184:
176:
173:
169:
165:
157:
154:
149:
145:
137:
134:
129:
125:
117:
113:
110:
107:
103:
100:
95:
91:
85:
82:
79:
75:
71:
67:
64:
63:Pharmaceutics
61:
57:
54:
50:
47:
44:
39:
35:
31:
27:
22:
16:
683:. Retrieved
673:
661:. Retrieved
657:The Guardian
656:
647:
635:. Retrieved
631:Market Watch
630:
622:
612:28 September
610:. Retrieved
606:
596:
584:. Retrieved
580:
570:
561:
554:. Retrieved
545:
536:
524:. Retrieved
519:
510:
498:. Retrieved
494:
485:
473:. Retrieved
461:
452:
440:. Retrieved
431:
419:. Retrieved
415:the original
410:
401:
389:. Retrieved
364:. Retrieved
296:
288:
284:
276:Santa Monica
273:
262:
232:
221:division of
216:
182:
181:
77:Headquarters
33:Company type
15:
586:15 November
556:7 September
546:uspsoig.gov
366:22 February
205:and on the
712:Categories
362:. Indivior
339:References
293:Operations
265:MassHealth
153:Net income
88:Key people
470:0362-4331
258:treatment
255:addiction
43:Traded as
685:22 March
442:22 March
421:21 March
391:22 March
303:Naloxone
301:and its
245:towards
243:patients
239:Suboxone
199:Suboxone
183:Indivior
105:Products
94:Chairman
59:Industry
19:Indivior
663:21 June
637:21 June
526:11 July
520:Reuters
500:11 July
475:11 July
311:cocaine
299:Subutex
247:doctors
213:History
171:Website
115:Revenue
69:Founded
51::
468:
307:opioid
280:NASDAQ
269:felony
360:(PDF)
319:world
687:2015
665:2024
639:2024
614:2023
588:2022
558:2020
528:2019
502:2019
477:2019
466:ISSN
444:2015
423:2015
393:2015
368:2023
235:drug
195:drug
72:1994
53:INDV
99:CEO
49:LSE
714::
655:.
605:.
579:.
560:.
548:.
544:.
518:.
493:.
460:.
411:RB
409:.
376:^
346:^
321:.
260:.
237:,
230:.
209:.
197:,
164:$
144:$
124:$
689:.
667:.
641:.
616:.
590:.
530:.
504:.
479:.
446:.
425:.
395:.
370:.
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.
